Pfizer opens new biotech plant in Sweden
This article was originally published in Scrip
Executive Summary
Pfizer has opened a new manufacturing plant at its facility in Strängnäs, Sweden, for the production of biologics. The plant, at around 6,000m2, is Sweden's largest biomanufacturing facility and cost Pfizer approximately €150 million.